Filing Details

Accession Number:
0001209582-11-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-17 14:23:08
Reporting Period:
2011-11-15
Filing Date:
2011-11-17
Accepted Time:
2011-11-17 14:23:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Vermillion Inc. VRML In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1209582 A Bruce Huebner C/O Vermillion, Inc.
12117 Bee Caves Rd, Bldg 3, Ste 100
Austin TX 78738
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-15 4,352 $1.26 13,847 No 4 P Direct
Common Stock Acquisiton 2011-11-16 26,580 $1.77 40,427 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price listed in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.24 to $1.29, inclusive. The reporting person undertakes to provide to Vermillion, Inc., any security holder of Vermillion, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.72 to $1.82, inclusive.